Trial intelligence / Profile preview

Tranexamic acid for reducing blood loss after vaginal delivery

PACTR202010828881019Phase 3Completed

Sponsor
Dr Igboke Francis N
Start
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranexamic acid in postpartum hemorrhage (PPH) (2 arms), sponsored by Dr Igboke Francis N. Primary endpoint: Estimated blood loss following vaginal delivery. Started Jun 2017; status: completed.

02

Drugs

tranexamic acid
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on PACTR202010828881019.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202010828881019.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call